Abs 1008 at #ACR22 shows endothelial dysfunction found in SpA pts assoc'd with worsening mSASSS, time of disease evolution, BASMI and BASFI, and CV plaques in axSpA. @RheumNow https://t.co/7Zxl4PcPfR https://t.co/3cAqigHtNU

The great debate Pre-RA to treat or not to treat? @HaniElgabalawy @Janetbirdope What a conversation with a patient at-risk of RA would look like based on current literature. Would you suggest to treat? If I was Mr Jones, I wouldn’t buy it. #ACRdebate #ACR22 @RheumNow https://t.co/vEj4KOauzz

Abstr #1037 evaluated BASDAI vs ASDAS in PsA w/ axial dx Both ASDAS & BASDAI showed - strong correlation w/ pt pain & Global Assessment - weak correlation in tender and swollen joint counts and enthesitis #ACR22 @RheumNow #axSpA #PsA https://t.co/EunXIwzn3M

The Great Debate! Should you treat pre-clinical RA? US erosions in 5th MTPs predict clinical arthritis in +CCP "Pre-RA" patients ~15% of patients will develop RA @RheumNow #ACR22 https://t.co/jS2YMlF4iO

Danish registry, 11000+ pts w/ sarcoidosis: > incidence young males > IR if born after 1976 in males IRR 1.22, no diff in females 1976 = yr systematic BCG vaccination stopped Attributed to ↘️ intake BCG vax Underlying mechanism? https://t.co/At3dUwIgES Abs#1111 #ACR22 @Rheumnow https://t.co/gArfdAVapD

The Great Debate! Should you treat pre-clinical RA? "The more good factors you have, the less likely you will develop RA" - Janet Pope Never smoker, normal BMI, low EtOH, exercise, healthy diet @RheumNow #ACR22 https://t.co/jIMOn8ht6u

70% of #AOSD pts were females! Large HCA database study - incidence rate - 0.16 - 0.21 per 100,000 (similar to French studies). 24% required ICU level of care, 12% had PNA (fig) Mortality is higher than other cohorts - 3.2% #ACR22 @RheumNow abst#0829 https://t.co/fcFUnExYOE

🤓Active learning creates a greater + impact in patient care using cognitive errors metacognition - study by Dr Milne et al. ☑️Reflection, #metacognition enhances clinical competence, incorporate in curriculum #ACR22 @RheumNow #meded @rheumarhyme @PhRheumaJr @GerRheumDoc https://t.co/veefYToXBV

Romo works even better in higher risk patients. More ammunition to use up-front. Availability is a limiting factor though. @RheumNow #ACR22 #osteoporosis https://t.co/90X97jVJcP

Dr. Jack Cush discusses uptake of #telemedicine in 2020 and the relative decline of uptake since then: @RheumNow -- What's your take on continuing to use #telehealth for rheum visits? #ACR22 https://t.co/OB5Wnnq6Fh

“Go digital or go home” -- Dr Jack Cush says on #telemedicine in a session at #ACR22 @RheumNow https://t.co/4PzGgS900t